Rating History for Prelude Therapeutics (PRLD) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for PRLD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/17/2026 Joyce Zhou New Coverage Overweight
(N/A)		 12.00
(N/A)		 4.52
(3.26)		 -27.88% Details